Cotinga Pharmaceuticals Inc.
COTQF
$0.0001
$0.000.00%
OTC PK
| 01/31/2020 | 10/31/2019 | 07/31/2019 | 04/30/2019 | 01/31/2019 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 106.60% | -- | -57.34% | -74.32% | -88.05% |
| Gross Profit | -106.60% | -- | 57.34% | 74.32% | 88.05% |
| SG&A Expenses | 15.93% | -21.17% | -37.08% | -46.70% | -67.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.01% | -11.94% | -45.60% | -55.75% | -75.99% |
| Operating Income | -34.01% | 11.94% | 45.60% | 55.75% | 75.99% |
| Income Before Tax | -92.96% | -6.85% | 47.29% | 42.98% | 79.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -92.96% | -6.85% | 47.29% | 42.98% | 79.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.96% | -6.85% | 47.29% | 42.98% | 79.22% |
| EBIT | -34.01% | 11.94% | 45.60% | 55.75% | 75.99% |
| EBITDA | -40.08% | 10.40% | 45.53% | 56.38% | 76.95% |
| EPS Basic | -91.67% | -6.36% | 47.67% | 57.20% | 84.16% |
| Normalized Basic EPS | -91.67% | -6.48% | 47.44% | 66.24% | 84.17% |
| EPS Diluted | -91.67% | -6.36% | 47.67% | 57.20% | 84.16% |
| Normalized Diluted EPS | -91.67% | -6.48% | 47.44% | 66.24% | 84.17% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.53% | 33.25% | 31.76% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.53% | 33.25% | 31.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |